Quantbot Technologies LP Veracyte, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $61,240 - $119,760	4,000 New	4,000 $94,000
Q2 2022 Aug 09, 2022	BUY	$15.45 - $29.52 $439,428 - $839,607	28,442 Added 1072.47%	31,094 $618,000
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $58,184 - $112,736	2,652 New	2,652 $73,000
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $78,820 - $117,477	-2,184 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$35.62 - $52.97 $7,195 - $10,699	-202 Reduced 8.47%	2,184 $101,000
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $119,407 - $205,247	-3,625 Reduced 60.31%	2,386 $95,000
Q1 2021 May 14, 2021	BUY	$44.47 - $81.38 $262,862 - $481,037	5,911 Added 5911.0%	6,011 $323,000
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $3,249 - $6,188	100 New	100 $4,000
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $26,257 - $34,023	-1,100 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$22.1 - $28.56 $24,310 - $31,416	1,100 New	1,100 $31,000

311

82M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.